Single nucleotide polymorphisms in obesity-related genes and all-cause and cause-specific mortality: a prospective cohort study

被引:21
作者
Gallicchio, Lisa [1 ,2 ]
Chang, Howard H. [3 ]
Christo, Dana K. [2 ]
Thuita, Lucy [2 ]
Huang, Han Yao [2 ]
Strickland, Paul [4 ]
Ruczinski, Ingo [3 ]
Clipp, Sandra [2 ]
Helzlsouer, Kathy J. [1 ,2 ]
机构
[1] Mercy Med Ctr, Weinberg Ctr Womens Hlth & Med, Prevent & Res Ctr, Baltimore, MD 21202 USA
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA
[3] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA
[4] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA
来源
BMC MEDICAL GENETICS | 2009年 / 10卷
关键词
GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; CHILDHOOD OBESITY; ADULT OBESITY; RISK LOCI; OVERWEIGHT; LONGEVITY; VARIANTS; LEPTIN; CENTENARIANS;
D O I
10.1186/1471-2350-10-103
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: The aim of this study was to examine the associations between 16 specific single nucleotide polymorphisms (SNPs) in 8 obesity-related genes and overall and cause-specific mortality. We also examined the associations between the SNPs and body mass index (BMI) and change in BMI over time. Methods: Data were analyzed from 9,919 individuals who participated in two large community-based cohort studies conducted in Washington County, Maryland in 1974 (CLUE I) and 1989 (CLUE II). DNA from blood collected in 1989 was genotyped for 16 SNPs in 8 obesity-related genes: monoamine oxidase A (MAOA), lipoprotein lipase (LPL), paraoxonase 1 and 2 (PON1 and PON2), leptin receptor (LEPR), tumor necrosis factor-a (TNF alpha), and peroxisome proliferative activated receptor-gamma and -delta (PPARG and PPARD). Data on height and weight in 1989 (CLUE II baseline) and at age 21 were collected from participants at the time of blood collection. All participants were followed from 1989 to the date of death or the end of follow-up in 2005. Cox proportional hazards regression was used to obtain the relative risk (RR) estimates and 95% confidence intervals (CI) for each SNP and mortality outcomes. Results: The results showed no patterns of association for the selected SNPs and the all-cause and cause-specific mortality outcomes, although statistically significant associations (p < 0.05) were observed between PPARG rs4684847 and all-cause mortality (CC: reference; CT: RR 0.99, 95% CI 0.89, 1.11; TT: RR 0.60, 95% CI 0.39, 0.93) and cancer-related mortality (CC: reference; CT: RR 1.01, 95% CI 0.82, 1.25; TT: RR 0.22, 95% CI 0.06, 0.90) and TNF alpha rs1799964 and cancer-related mortality (TT: reference; CT: RR 1.23, 95% CI 1.03, 1.47; CC: RR 0.83, 95% CI 0.54, 1.28). Additional analyses showed significant associations between SNPs in LEPR with BMI (rs1137101) and change in BMI over time (rs1045895 and rs1137101). Conclusion: Findings from this cohort study suggest that the selected SNPs are not associated with overall or cause-specific death, although several LEPR SNPs may be related to BMI and BMI change over time.
引用
收藏
页数:9
相关论文
共 45 条
  • [1] Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old
    Adams, Kenneth F.
    Schatzkin, Arthur
    Harris, Tamara B.
    Kipnis, Victor
    Mouw, Traci
    Ballard-Barbash, Rachel
    Hollenbeck, Albert
    Leitzmann, Michael F.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (08) : 763 - 778
  • [2] Genetic analysis of Paraoxonase (PON1) locus reveals an increased frequency of Arg192 allele in centenarians
    Bonafè, M
    Marchegiani, F
    Cardelli, M
    Olivieri, F
    Cavallone, L
    Giovagnetti, S
    Pieri, C
    Marra, M
    Antonicelli, R
    Troiano, L
    Gueresi, P
    Passeri, G
    Berardelli, M
    Paolisso, G
    Barbieri, M
    Tesei, S
    Lisa, R
    De Benedicts, G
    Franceschi, C
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 (05) : 292 - 296
  • [3] Obesity and mortality
    Calle, EE
    Teras, LR
    Thun, MJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (20) : 2197 - 2199
  • [4] The paraoxonases: role in human diseases and methodological difficulties in measurement
    Camps, Jordi
    Marsillach, Judit
    Joven, Jorge
    [J]. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2009, 46 (02) : 83 - 106
  • [5] Population stratification and spurious allelic association
    Cardon, LR
    Palmer, LJ
    [J]. LANCET, 2003, 361 (9357) : 598 - 604
  • [6] Paraoxonase 1 polymorphisms and survival
    Christiansen, L
    Bathum, L
    Frederiksen, H
    Christensen, K
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2004, 12 (10) : 843 - 847
  • [7] Variation in FTO contributes to childhood obesity and severe adult obesity
    Dina, Christian
    Meyre, David
    Gallina, Sophie
    Durand, Emmanuelle
    Koerner, Antje
    Jacobson, Peter
    Carlsson, Lena M. S.
    Kiess, Wieland
    Vatin, Vincent
    Lecoeur, Cecile
    Delplanque, Jerome
    Vaillant, Emmanuel
    Pattou, Francois
    Ruiz, Juan
    Weill, Jacques
    Levy-Marchal, Claire
    Horber, Fritz
    Potoczna, Natascha
    Hercberg, Serge
    Le Stunff, Catherine
    Bougneres, Pierre
    Kovacs, Peter
    Marre, Michel
    Balkau, Beverley
    Cauchi, Stephane
    Chevre, Jean-Claude
    Froguel, Philippe
    [J]. NATURE GENETICS, 2007, 39 (06) : 724 - 726
  • [8] Cause-specific excess deaths associated with underweight, overweight, and obesity
    Flegal, Katherine M.
    Graubard, Barry I.
    Williamson, David F.
    Gail, Mitchell H.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (17): : 2028 - 2037
  • [9] Excess deaths associated with underweight, overweight, and obesity
    Flegal, KM
    Graubard, BI
    Williamson, DF
    Gail, MH
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (15): : 1861 - 1867
  • [10] Genes implicated in serotonergic and dopaminergic functioning predict BMI categories
    Fuemmeler, Bernard F.
    Agurs-Collins, Tanya D.
    Mcclernon, F. Joseph
    Kollins, Scott H.
    Kail, Melanie E.
    Bergen, Andrew W.
    Ashley-Koch, Allison E.
    [J]. OBESITY, 2008, 16 (02) : 348 - 355